The Ohio State University

Participants accepted until:  12/2012

Participant criteria:  Children ages 5 to 13, inclusive, with ASD and with ADHD symptoms

This is a clinical trial studying whether the FDA-approved medication called atomoxetine (Strattera) and/or Parent Management Training has an effect on hyperactivity and noncompliance in children with an autism spectrum disorder.

Participants will be randomly assigned (as if by tossing a coin) to one of the following four options for the first 10 weeks of the study:

• Atomoxetine (Strattera) only
• A placebo (that is a fake pill) only
• Atomoxetine and Parent Management Training
• A placebo (that is a fake pill) and Parent Management Training

Institutions Conducting Study:  The Ohio State University, University of Pittsburgh, University of Rochester (NY)

HSRB/IRB granting organization:  IRB

Individuals Conducting Study:  Michael G. Aman, Ph.D., Eugene Arnold, M.Ed.

Supervising Professor:  Michael G. Aman

Weblink:  www.autism-adhd.org

To participate, contact:  Pam Sayre 614-688-8214;  This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Click HERE for a flier with more information.